Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Liraglutide activates key brain circuits to trigger weight loss in obesity
Researchers uncover how liraglutide targets specific brain regions to suppress appetite and promote significant weight loss through GLP-1 receptor activation.
Obesity drug liraglutide helps children lose weight, study shows
Severe obesity is already a significant problem for many children, especially since obese children often become obese adults. Could the now popular weight-loss injection drugs be a solution for those under 18?
Weight loss drug liraglutide shows promise for younger children with obesity, study finds
Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got a placebo, according to a new study.
Semaglutide Bests Liraglutide in Long-Term Weight Loss
Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide after 1 year.
Weight-loss drug Saxenda might help obese kids as young as 6
The weight-loss drug liraglutide (Saxenda) helped obese children lower their BMI and reach a healthier weight, researchers report.
Semaglutide vs. liraglutide: One-year weight loss efficacy in obesity and type 2 diabetes
Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at least 10% weight reduction as compared to 23.1% among those prescribed semaglutide for T2D, 28.6% liraglutide for obesity, and 12.3% liraglutide for T2D groups.
Exercising On Weight Loss Drugs May Have a Surprising Side Effect (Hint: It's Not Just More Weight Loss)
A recent study suggests that people taking the GLP-1 liraglutide experienced more bone loss than people who exercised during the same time period. However, the study also found that exercising while taking liraglutide and other GLP-s may help prevent bone loss.
Weight-loss drug liraglutide found to be 'safe and effective' for kids as young as 6
Novo Nordisk asked US regulators to approve the drug for children ages 6 to 11. In the EU, it's available for adolescents as young as 12.
Weight-loss drug Saxenda effective for kids as young as 6, study shows
By JONEL ALECCIA A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study shows. Liraglutide
Weight-loss drug could be used on children as young as six
Your donation makes it possible for us to keep doing this important work, keeping you informed every step of the way to the November election The maker of a weight loss drug has asked regulators to allow them to expand the use of the medication down to the age of six.
SouthFlorida Reporter
6h
These 4 Factors Can Impact How Many Pounds You’ll Lose on Weight Loss Drugs Like Ozempic
Researchers used real-world data to identify key factors for long-term weight loss for patients taking GLP-1 drugs like Ozempic and Wegovy.
Medpage Today on MSN
13d
Liraglutide Helped Cut BMI in Kids With Obesity as Young as 6
Liraglutide (Saxenda) added to lifestyle intervention helped reduce BMI in young children with obesity, the phase IIIa SCALE ...
Medscape
11d
Liraglutide Reduces BMI by Almost 6% in Children Aged 6 to 12
Liraglutide is the first GLP-1 agonist to show benefit in this age group and could provide young patients a much-needed ...
4d
Achieving Weight Loss: New Study Identifies Key Factors of Success
The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...
ConsumerAffairs
4d
The battle of the weight loss injectables has a clear winner
In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...
GlobalData on MSN
6d
Pipeline Moves: Novo Nordisk’s liraglutide scores in Phase III paediatric trial
The Clinical Trials Arena team investigates assets in infectious diseases, metabolic disorders, oncology and ophthalmology.
MedPage Today
6d
What Factors Predict Clinically Meaningful Weight Loss With GLP-1 Agonists?
Recently, GLP-1 receptor agonist medications have been prescribed more commonly, in part due to their ability to produce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Weight loss
Ozempic
Semaglutide
Feedback